A lot has been stated about the Maintenance of Certification (MOC) implemented by the American Board of Internal Medicine (ABIM,) and many physicians, regardless of specialty, have been opposed to the MOC as it adds cost, burden, and takes away from patient care. This led Dr. Aaron Goodman from UCSD to start a petition to end the MOC, which gathered unwavering support with over 10,000 signatures in 2 weeks. In response, Dr. Richard Baron, the president and CEO of ABIM, has agreed to come on the show to address the concerns raised by physicians and to answer questions that have flooded all social media channels since the petition started.
What is the history of certification, recertification, and MOC? What is the “Grandfather” rule? What about data? COI? Cost? Burnout? Does the MOC really lead to better patient care? Why not stick to state-regulated CME courses? These issues are top-of-mind for a large number of physicians who are certified by the ABIM.
You will not want to miss this heated, yet respectful and civil, discussion.
In the podcast, there is a mention of COIs. The ABIM has provided links to their COI.
Dr. Baron’s specific COI are also listed: https://www.abim.org/about/leadership/#baron
The ABIM Board of Directors page lists all of their COIs as well: https://www.abim.org/about/boards-and-committees/governance/board-of-directors/
Here is the page for all the Specialty Boards: https://www.abim.org/about/boards-and-committees/
View the petition: https://www.change.org/p/eliminate-abims-moc-requirement
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
